Press Releases 2012 2011 2010 Press Releases Cortex Reports Fourth Quarter and Year End Operating Results IRVINE, CA (April 8, 2010) Cortex Pharmaceuticals, Inc. (OTCBB (CORX)) reported a net loss applicable to common stock of $1,599,000, or $0.02 per share for the quarter ended December 31, 2009 co...

Press Releases 2012 2011 2010 Press Releases Cortex Reports Fourth Quarter and Year End Operating Results IRVINE, CA (March 30, 2012) Cortex Pharmaceuticals, Inc. (OTCBB (CORX)) reported net income of approximately $832,000, or $0.01 per share, for the quarter ended December 31, 2011, compared with ...

Press Releases 2012 2011 2010 Press Releases Cortex Pharmaceuticals and Pier Pharmaceuticals Consummate Merger Merger Creates New Biotechnology Company Focused on Brain-Controlled Breathing Disorders Irvine, CA & Louisville, CO August 14, 2012 Cortex Pharmaceuticals, Inc. (CORX: OTCBB) and Pier ...

Brain-Controlled Breathing Disorders Breathing is a vital function that is controlled by the rhythmic firing of neurons in a few specific brain regions deep in... Sleep Apnea According to the National Heart Lung and Blood Institute sleep apnea affects some 18 million Americans. In fact, according to...

Press Releases 2012 2011 2010 Press Releases Cortex Sells Selected Ampakine Compounds and Rights to Respiratory Depression Indication to Biovail Purchase Price of $10 Million and up to $15 Million Clinical Development Milestones IRVINE, CA (March 26, 2010) Cortex Pharmaceuticals, Inc. (OTCBB (CORX.O...